交易 PDS Biotechnology Corporation - PDSB CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
PDS Biotechnology Corp ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 2.87 | 0.17 | 6.30% | 2.70 | 2.98 | 2.66 |
Apr 17, 2024 | 2.69 | -0.10 | -3.58% | 2.79 | 2.79 | 2.65 |
Apr 16, 2024 | 2.77 | -0.01 | -0.36% | 2.78 | 2.90 | 2.66 |
Apr 15, 2024 | 2.79 | -0.38 | -11.99% | 3.17 | 3.19 | 2.78 |
Apr 12, 2024 | 3.16 | -0.12 | -3.66% | 3.28 | 3.36 | 3.12 |
Apr 11, 2024 | 3.34 | 0.19 | 6.03% | 3.15 | 3.38 | 3.15 |
Apr 10, 2024 | 3.12 | 0.02 | 0.65% | 3.10 | 3.17 | 3.05 |
Apr 9, 2024 | 3.25 | -0.03 | -0.91% | 3.28 | 3.29 | 3.07 |
Apr 8, 2024 | 3.29 | 0.06 | 1.86% | 3.23 | 3.37 | 3.11 |
Apr 5, 2024 | 3.20 | -0.01 | -0.31% | 3.21 | 3.35 | 3.15 |
Apr 4, 2024 | 3.26 | -0.35 | -9.70% | 3.61 | 3.68 | 3.20 |
Apr 3, 2024 | 3.65 | -0.08 | -2.14% | 3.73 | 3.74 | 3.59 |
Apr 2, 2024 | 3.68 | -0.18 | -4.66% | 3.86 | 3.91 | 3.61 |
Apr 1, 2024 | 3.98 | 0.00 | 0.00% | 3.98 | 4.00 | 3.76 |
Mar 28, 2024 | 3.93 | 0.05 | 1.29% | 3.88 | 4.53 | 3.88 |
Mar 27, 2024 | 3.80 | -0.19 | -4.76% | 3.99 | 4.28 | 3.59 |
Mar 26, 2024 | 4.45 | -0.29 | -6.12% | 4.74 | 4.88 | 4.45 |
Mar 25, 2024 | 4.70 | 0.18 | 3.98% | 4.52 | 4.79 | 4.52 |
Mar 22, 2024 | 4.59 | -0.21 | -4.37% | 4.80 | 4.84 | 4.54 |
Mar 21, 2024 | 4.84 | 0.04 | 0.83% | 4.80 | 4.86 | 4.70 |
PDS Biotechnology Corporation Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 13, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 PDS Biotechnology Corp Earnings Release Q1 2024 PDS Biotechnology Corp Earnings ReleaseForecast(預報) -返回 - |
Friday, July 12, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 PDS Biotechnology Corp Annual Shareholders Meeting PDS Biotechnology Corp Annual Shareholders MeetingForecast(預報) -返回 - |
Monday, August 12, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 PDS Biotechnology Corp Earnings Release Q2 2024 PDS Biotechnology Corp Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | ||||
總營業費用 | 41.6724 | 21.4393 | 14.9024 | 7.70005 | 43.0966 |
銷售/一般/行政費用,總計 | 12.2414 | 10.1848 | 6.96233 | 8.91149 | 15.0205 |
研究與開發 | 29.431 | 11.2545 | 7.92445 | 6.09958 | 16.0688 |
營業收入 | -41.6724 | -21.4393 | -14.9024 | -7.70005 | -43.0966 |
利息收入(費用),非經營淨值 | -0.38134 | 0.00435 | 0.05501 | 0.31993 | -0.55338 |
其他,淨值 | 0 | 0 | |||
稅前淨收入 | -42.0538 | -21.435 | -14.8474 | -7.38012 | -43.6499 |
稅後淨收入 | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
未計算非常項目前的淨收益 | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
淨收入 | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
普通股股東可獲收益 (含非經常性項目) | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
攤薄淨收入 | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
攤薄後加權平均股 | 28.5992 | 25.5971 | 16.745 | 4.86808 | 1.56211 |
扣除特別項目的每股攤薄盈利 | -1.42853 | -0.66095 | -0.88667 | -1.43765 | -26.1621 |
每股正常攤薄盈利 | -1.42853 | -0.66095 | -0.85692 | -2.41384 | -21.1658 |
非常規項目總計 | 0 | ||||
異常費用(收入) | 0 | -7.31102 | 12.0073 | ||
Depreciation / Amortization | 0.01561 | 0 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 12.6962 | 9.42241 | 18.8214 | 7.2792 | 7.09265 |
銷售/一般/行政費用,總計 | 4.69132 | 3.57873 | 2.66627 | 2.92621 | 3.33101 |
研究與開發 | 8.00485 | 5.84369 | 16.1551 | 4.35299 | 3.76165 |
營業收入 | -12.6962 | -9.42241 | -18.8214 | -7.2792 | -7.09265 |
利息收入(費用),非經營淨值 | -0.24475 | -0.23751 | -0.14525 | 0.07455 | |
稅前淨收入 | -12.9409 | -9.65992 | -19.1377 | -7.42445 | -7.01811 |
稅後淨收入 | -11.5349 | -9.65992 | -19.1377 | -7.42445 | -5.8192 |
未計算非常項目前的淨收益 | -11.5349 | -9.65992 | -19.1377 | -7.42445 | -5.8192 |
淨收入 | -11.5349 | -9.65992 | -19.1377 | -7.42445 | -5.8192 |
普通股股東可獲收益 (不含非經常性項目) | -11.5349 | -9.65992 | -19.1377 | -7.42445 | -5.8192 |
普通股股東可獲收益 (含非經常性項目) | -11.5349 | -9.65992 | -19.1377 | -7.42445 | -5.8192 |
攤薄淨收入 | -11.5349 | -9.65992 | -19.1377 | -7.42445 | -5.8192 |
攤薄後加權平均股 | 30.8025 | 30.428 | 29.0379 | 28.4587 | 28.4516 |
扣除特別項目的每股攤薄盈利 | -0.37448 | -0.31747 | -0.65906 | -0.26089 | -0.20453 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.37448 | -0.31747 | -0.65906 | -0.26089 | -0.20453 |
其他,淨值 | -0.31633 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 76.4804 | 66.8402 | 30.3372 | 14.4702 | 35.6511 |
現金和短期投資 | 73.8202 | 65.2426 | 28.8396 | 12.1617 | 34.6455 |
現金等價物 | 73.8202 | 65.2426 | 28.8396 | 12.1617 | 34.6455 |
預付的費用 | 2.66023 | 1.59757 | 1.49767 | 2.30846 | 1.00559 |
總資産 | 77.0079 | 67.1979 | 30.8904 | 14.4913 | 36.221 |
物業/廠房/設備,總計 - 淨額 | 0.52753 | 0.3577 | 0.55315 | 0.02105 | 0.42695 |
物業/廠房/設備,總計 - 總額 | 0.64295 | 0.47303 | 0.66313 | 0.11542 | 0.87862 |
累計折舊,總計 | -0.11542 | -0.11533 | -0.10998 | -0.09437 | -0.45166 |
其他長期資産,總計 | 0 | 0.14287 | |||
流動負債總額 | 9.82104 | 3.75603 | 3.27045 | 2.79355 | 6.38175 |
應付賬款 | 1.21929 | 1.3094 | 1.41522 | 1.19772 | 0.39945 |
預提費用 | 8.54514 | 2.44663 | 1.85523 | 1.09764 | 0.38616 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.05661 | 0 | |||
其他流動負債,總計 | 0 | 0.49819 | 5.59614 | ||
負債總額 | 33.0059 | 3.98746 | 3.7608 | 2.79355 | 6.38175 |
長期債務總額 | 23.1849 | 0 | 0 | 0 | 0 |
長期債務 | 23.0208 | 0 | 0 | ||
股權 | 44.002 | 63.2104 | 27.1296 | 11.6977 | 29.8392 |
普通股 | 0.00996 | 0.00939 | 0.00735 | 0.00174 | 0.01059 |
額外實收資本 | 145.55 | 123.905 | 70.9073 | 40.6337 | 222.645 |
留存收益(累計赤字) | -101.558 | -60.7036 | -43.7851 | -28.9377 | -192.816 |
總負債和股東權益 | 77.0079 | 67.1979 | 30.8904 | 14.4913 | 36.221 |
已發行普通股總數 | 30.1703 | 28.4486 | 22.2616 | 5.28124 | 1.5725 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
其他負債,總計 | 0 | 0.23143 | 0.49035 | 0 | |
資本租賃義務 | 0.16401 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 56.8384 | 63.3509 | 67.9734 | 76.4804 | 74.4113 |
現金和短期投資 | 54.2514 | 60.625 | 65.1994 | 73.8202 | 71.6424 |
現金等價物 | 54.2514 | 60.625 | 65.1994 | 73.8202 | 71.6424 |
預付的費用 | 2.58703 | 2.72596 | 2.77399 | 2.66023 | 2.76891 |
總資産 | 57.1878 | 63.7542 | 68.4486 | 77.0079 | 74.8868 |
物業/廠房/設備,總計 - 淨額 | 0.34941 | 0.4033 | 0.47526 | 0.52753 | 0.47542 |
流動負債總額 | 9.15383 | 7.90419 | 4.12954 | 9.82104 | 4.84114 |
應付賬款 | 5.36656 | 4.41491 | 2.07206 | 1.21929 | 2.03739 |
預提費用 | 3.73273 | 3.43598 | 2.00537 | 8.54514 | 2.74248 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 32.704 | 31.3101 | 27.4377 | 33.0059 | 27.8279 |
長期債務總額 | 23.5502 | 23.4059 | 23.3081 | 23.1849 | 22.9868 |
其他負債,總計 | 0 | 0 | |||
股權 | 24.4838 | 32.4442 | 41.0109 | 44.002 | 47.0588 |
普通股 | 0.01023 | 0.01019 | 0.01014 | 0.00996 | 0.00939 |
額外實收資本 | 158.076 | 155.187 | 152.219 | 145.55 | 129.47 |
留存收益(累計赤字) | -133.602 | -122.753 | -111.218 | -101.558 | -82.4207 |
總負債和股東權益 | 57.1878 | 63.7542 | 68.4486 | 77.0079 | 74.8868 |
已發行普通股總數 | 31.0078 | 30.8682 | 30.7236 | 30.1703 | 28.4587 |
長期債務的當前部分/資本租賃 | 0.05454 | 0.05331 | 0.05211 | 0.05661 | 0.06127 |
長期債務 | 23.4128 | 23.2544 | 23.1428 | 23.0208 | 22.9097 |
資本租賃義務 | 0.1374 | 0.15151 | 0.16529 | 0.16401 | 0.07713 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -40.8549 | -16.9185 | -14.8474 | -6.99861 | -40.868 |
經營活動産生的現金 | -25.7097 | -12.4861 | -13.1491 | -18.0735 | -33.1533 |
經營活動産生的現金 | 0.04908 | 0.00536 | 0.01561 | 0.09841 | 0.17435 |
非現金物品 | 10.6211 | 4.35124 | 0.61297 | -6.22017 | 10.9689 |
已付現金利息 | 0.85222 | 0 | 1.05117 | ||
營運資金的變化 | 4.47498 | 0.07582 | 1.06967 | -4.5716 | -3.4285 |
投資活動産生的現金 | 0 | 29.3815 | 0 | ||
資本支出 | 0 | ||||
融資活動産生的現金 | 34.2872 | 48.8891 | 29.827 | 0.75 | -20.2688 |
融資現金流項目 | -0.72029 | -0.99 | |||
股票的發行(報廢),淨額 | 10.0075 | 48.8891 | 29.827 | 0.75 | 0.7212 |
債務的發行(退還),淨額 | 25 | 0 | -20 | ||
現金淨變化 | 8.57754 | 36.4031 | 16.6778 | 12.058 | -53.4221 |
Deferred Taxes | 0 | -0.38151 | |||
Cash Taxes Paid | 0 | ||||
其他投資現金流量項目,總計 | 0 | 29.3815 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.65992 | -40.8549 | -21.7172 | -14.2927 | -8.47352 |
Cash From Operating Activities | -13.1886 | -25.7097 | -18.1808 | -12.2879 | -6.36901 |
Cash From Operating Activities | 0.01411 | 0.04908 | 0.0375 | 0.00009 | 0.00009 |
Non-Cash Items | 2.26257 | 10.6211 | 4.07542 | 2.59809 | 1.18923 |
Changes in Working Capital | -5.8054 | 4.47498 | -0.57652 | -0.59332 | 0.9152 |
Cash From Financing Activities | 4.56786 | 34.2872 | 24.5806 | 0.02992 | 0.00749 |
Issuance (Retirement) of Stock, Net | 4.58852 | 10.0075 | 0.02992 | 0.02992 | 0.00749 |
Net Change in Cash | -8.62078 | 8.57754 | 6.39982 | -12.2579 | -6.36152 |
Cash Interest Paid | 0.96685 | 0.85222 | 0.0625 | ||
Financing Cash Flow Items | -0.72029 | -0.44933 | |||
Issuance (Retirement) of Debt, Net | -0.02067 | 25 | 25 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
303A College Road East
PRINCETON
NEW JERSEY 08540
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易